Antifungals: 2004 and Beyond

BioSeeker Group AB
October 19, 2004
77 Pages - SKU: BIOS1063671
License type:
Point of Care Diagnostics Bundle (POC Diagnostic Markets, POC Diagnostics for Emerging Infectious Diseases, POC Dx in Physician Office Labs)
3/2/2012 | published by: Kalorama Information
Point of Care Diagnostics represents one of the highest-growth industries in testing. This bundle allows Kalorama Information customers to save by purchasing one PDF which contains our most popular previously published reports on point-of-care  |  more...
$3,995.00
2012 Global Infectious Disease Testing Market Outlook: Growth Opportunities and Strategies
4/20/2012 | published by: Venture Planning Group
The infectious disease testing market is one of the most rapidly growing segments of the in vitro diagnostics industry, and the greatest challenge facing suppliers in the 21st century. Among the main driving forces  |  more...
$28,700.00
2012 Germany Infectious Disease Testing Market Outlook: Growth Opportunities and Strategies
4/20/2012 | published by: Venture Planning Group
This report presents a comprehensive analysis of the German infectious disease testing market, including: Major issues pertaining to the French laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market  |  more...
$5,900.00
Influenza – Pipeline Review, H1 2012
2/27/2012 | published by: Global Markets Direct
Influenza – Pipeline Review, H1 2012 Summary Global Markets Direct’s, 'Influenza - Pipeline Review, H1 2012', provides an overview of the Influenza therapeutic pipeline. This report provides information on the therapeutic development for Influenza, complete with latest  |  more...
$500.00
Anti-Infective Pharmaceuticals Market in India 2012
4/6/2012 | published by: Netscribes (India) Pvt. Ltd.
Anti-infective pharmaceuticals market in India is the largest contributor to domestic pharmaceutical sales, contributing around 18%. Since India has a huge patient pool, the Indian market is characterized by a huge demand for anti-infective drugs.  |  more...
$795.00
The 2012 Japanese Infectious Disease Testing Market
3/28/2012 | published by: Venture Planning Group
This report presents a comprehensive analysis of the Japanese infectious disease testing market, including: Major issues pertaining to the Japanese laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market  |  more...
$7,800.00
The 2012 Spanish Infectious Disease Testing Market
3/28/2012 | published by: Venture Planning Group
This report presents a comprehensive analysis of the Spanish infectious disease testing market, including: Major issues pertaining to the Spanish laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market  |  more...
$5,900.00
Understanding Regional Chinese Health Markets
3/15/2012 | published by: Espicom Healthcare Intelligence
Critical information and statistics on national and regional health infrastructure and provision. An essential source of detailed key business data.  |  more...
$690.00
Anthrax – Pipeline Review, H1 2012
3/19/2012 | published by: Global Markets Direct
Anthrax – Pipeline Review, H1 2012 Summary Global Markets Direct’s, 'Anthrax - Pipeline Review, H1 2012', provides an overview of the Anthrax therapeutic pipeline. This report provides information on the therapeutic development for Anthrax , complete with  |  more...
$500.00
Polio – Pipeline Review, H1 2012
3/19/2012 | published by: Global Markets Direct
Polio – Pipeline Review, H1 2012 Summary Global Markets Direct’s, 'Polio - Pipeline Review, H1 2012', provides an overview of the Polio therapeutic pipeline. This report provides information on the therapeutic development for Polio, complete with latest  |  more...
$500.00